The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

Researchers examine how the use of animal testing to identify endocrine-disrupting substances in the EU can be reduced. Although it is, in principle, possible to identify such substances without using ...

(MENAFN- EIN Presswire) EINPresswire/ -- The shift towards ethical and innovative testing methods is reshaping the landscape of product safety evaluation. As industries move away from traditional ...

In Vivo and In Silico Methods from Predictive Toxicology to Help Develop Precision Medicine Traditional in vivo animal methods for assessing safety and toxicity continue to be replaced by alternative ...